📑400 TRIOXIDO DE ARSENICO SOLUCION INYECTABLE AMPOLLA 10MG/10ML
Procurement process summary
This process is to purchase 400 trioxido de arsenico solucion inyectable ampolla 10mg/10ml.
This contract was awarded by 🇬🇹 UNIDAD NACIONAL DE ONCOLOGIA PEDIATRICA for an amount of GTQ 284,829 to 1 supplier. It was published on 2023-12-28 through open and its current status is Adjudicado
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇬🇹 UNIDAD NACIONAL DE ONCOLOGIA PEDIATRICA Buying unitnot reported Publication date2023-12-28 Contest statusAdjudicado DescriptionTRIOXIDO DE ARSENICO SOLUCION INYECTABLE AMPOLLA 10MG/10MLAwards
This award was granted to INSUPHARMA, S.A. DE C.V. by UNIDAD NACIONAL DE ONCOLOGIA PEDIATRICA for an amount of GTQ 284,829. The procurement process was conducted through open for the category of goods. The award was granted on 2023-12-29.
| Supplier | Amount | Award date |
|---|---|---|
| 🇸🇻 INSUPHARMA, S.A. DE C.V. | GTQ 284,829 | 2023-12-29 |
Market context and opportunities
The execution of this contract allows the entity UNIDAD NACIONAL DE ONCOLOGIA PEDIATRICA to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberGT_ocds-xqjsxa-21828210Publication date2023-12-28Contract datenot reportedAward date2023-12-29CategoriesgoodsPurchase modalityopenMethod detailsBienes y Suministros Importados (Art. 5 LCE)StatusAdjudicadoData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
